A recent study showing that inhibiting the activities of HDACs increased histone acetylation and enhanced hippocampal-dependent memory formation (34) further support our result that HDAC1 indeed plays a pathogenesis role in AD and may be a potential therapeutic target. This evidence concerns the gene HDAC1 and Alzheimer disease.